»À¿Í °üÀý °Ç°º¸Á¶Á¦ ½ÃÀå ±Ô¸ð : Á¦Ç°º°, Çüź°, ¼ÒºñÀÚº°, À¯Åë ä³Îº° ¼¼°è ¿¹Ãø(2024-2032³â)
Bone & Joint Health Supplements Market Size - By Product (Vitamin & Minerals, Collagen), Form (Capsule & Tablets, Powders), Consumer (Geriatric, Adults, Pregnant Women), Distribution Channel (Pharmacies, E-commerce), & Global Forecast (2024-2032)
»óǰÄÚµå
:
1426961
¸®¼Ä¡»ç
:
Global Market Insights Inc.
¹ßÇàÀÏ
:
2023³â 12¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 150 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»À¿Í °üÀý °Ç°º¸Á¶Á¦ »ê¾÷Àº Àα¸ °í·ÉÈ¿¡ ÀÇÇØ ÃËÁøµÇ¾î 2024-2032³â CAGR 7.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
°ñ´Ù°øÁõ, °üÀý¿° µî »À¿Í °üÀý °ü·Ã ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, Lancet Rheumatology¿¡ µû¸£¸é 2023³â¿¡´Â 30¼¼ ÀÌ»ó ¼¼°è Àα¸ÀÇ ¾à 15%°¡ °ñ°üÀý¿°À» ¾Î°í ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
»À¿Í °üÀý °Ç°À» ÁõÁøÇÏ´Â º¸ÃæÁ¦¸¦ º¹¿ëÇÏ´Â µî Àü½Å °Ç°À» À§ÇÑ Àû±ØÀûÀÎ Á¶Ä¡¸¦ ÃëÇÏ´Â »ç¶÷µéÀÌ ´Ã°í ÀÖ½À´Ï´Ù. ÇÇÆ®´Ï½º Æ®·»µå¿Í Ȱµ¿ÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ¼ÒºñÀÚµéÀº Ä®½·, ºñŸ¹ÎD, ¿À¸Þ°¡ 3 Áö¹æ»ê µî »ÀÀÇ °µµ¿Í À¯¿¬¼ºÀ» °ÈÇÏ´Â ÁÖ¿ä ¼ººÐÀ» ÇÔÀ¯ÇÑ Á¦Ç°À» ã°í ÀÖ½À´Ï´Ù.
¿À¸Þ°¡ 3 Áö¹æ»ê ºÐ¾ß´Â °üÀýÅëÀ» ¿ÏÈÇÏ´Â Ç׿°Áõ È¿°ú·Î ÀÎÇØ 2032³â±îÁö Å« ÆøÀÇ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¾îÀ¯¿¡ ÇÔÀ¯µÈ ÀÌ Çʼö Áö¹æ»êÀº ÃÖÀûÀÇ °ñ¹Ðµµ¸¦ À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¼ÒºñÀÚµéÀº Á¡Á¡ ´õ ÇコÄɾ ´ëÇÑ ÀÚ¿¬ÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ¼±È£Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ À¯¸®ÇÏ°Ô ÀÛ¿ëÇÒ °ÍÀÔ´Ï´Ù.
ºÐ¸» ºÎ¹®Àº »ýü ÀÌ¿ë·ü·Î ÀÎÇØ 2023³â°ú 2032³â »çÀÌ¿¡ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âÁ¸ÀÇ Á¤Á¦³ª ĸ½¶°ú ´Þ¸® ºÐ¸» º¸ÃæÁ¦´Â ºü¸£°Ô Èí¼öµÇ¾î ü³»¿¡¼ Çʼö ¿µ¾ç¼Ò¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºÐ¸» À¯ÇüÀº º¹¿ë·® ¸ÂÃãȰ¡ °¡´ÉÇϱ⠶§¹®¿¡ ¼ÒºñÀÚ´Â °³ÀÎÀÇ Çʿ信 µû¶ó ¼·Ãë·®À» ½±°Ô Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »À¿Í °üÀý °Ç° º¸Á¶Á¦ ½ÃÀå Á¡À¯À²Àº ¾ÆÀ¯¸£º£´Ù¿Í Áß±¹ ÀüÅë ÀÇÇÐ µî ÀüÅë °ü½À¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ 2023-2032³â Å« ÆøÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àεµ, Áß±¹ µîÀÇ ±¹°¡¿¡¼´Â ¾É¾Æ¼ »ýȰÇÏ´Â »ýȰ¹æ½ÄÀÇ º¸±Þ·ü Áõ°¡¿Í µµ½ÃÈ·Î ÀÎÇØ ±Ù°ñ°Ý°è ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °í´ë ¹æ½Ä°ú Çö´ë ¿µ¾ç °úÇÐÀ» °áÇÕÇÑ Çõ½ÅÀûÀÎ Á¦ÇüÀÇ Ã¤ÅÃÀº ÀÌ Áö¿ªÀÇ »ê¾÷ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå »À¿Í °üÀý °Ç°º¸Á¶Á¦ ½ÃÀå ÀλçÀÌÆ®
- ¾÷°è »óȲ
- ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
- ÃËÁø¿äÀÎ
- °í·ÉÈ Àα¸ÀÇ Áõ°¡
- »À°ü·Ã ÁúȯÀÇ À¯º´·ü »ó½Â
- ½ÄÀ̺¸ÃæÁ¦¿¡ ´ëÇÑ Àνİú ¼ö¿äÀÇ Áõ°¡
- ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
- º¸ÃæÁ¦¿¡ °ü·ÃµÈ ºÎÀÛ¿ë°ú ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á
- º¸ÃæÁ¦¿¡ °üÇÑ ÇÑÁ¤µÈ ÀÓ»ó µ¥ÀÌÅÍ
- ¼ºÀå °¡´É¼º ºÐ¼®
- ±ÔÁ¦ »óȲ
- PorterÀÇ »ê¾÷ ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå °æÀï ±¸µµ
- ¼·Ð
- ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
- ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
- °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
- Àü·« ´ë½Ãº¸µå
Á¦5Àå »À¿Í °üÀý °Ç°º¸Á¶Á¦ ½ÃÀå ÃßÁ¤¡¤ÁÖ¿ä µ¿Çâ ¿¹Ãø : Á¦Ç°º°
- ÁÖ¿ä µ¿Çâ : Á¦Ç°º°
- ºñŸ¹Î & ¹Ì³×¶ö
- Äݶó°Õ
- ±Û·çÄÚ»ç¹Î¡¤Äܵå·ÎÀÌÆ¾
- ¿À¸Þ°¡ 3 Áö¹æ»ê
- ±âŸ Á¦Ç°
Á¦6Àå »À¿Í °üÀý °Ç°º¸Á¶Á¦ ½ÃÀå Ã߻ꡤ¿¹Ãø : Çüź°
- ÁÖ¿ä µ¿Çâ : Çüź°
- ĸ½¶¡¤Á¤Á¦
- ºÐ¸»
- ¾×ü
- ±âŸ ÇüÅÂ
Á¦7Àå »À¿Í °üÀý °Ç°º¸Á¶Á¦ ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¼ÒºñÀÚº°
- ÁÖ¿ä µ¿Çâ : ¼ÒºñÀÚº°
- ³ëÀÎ Àα¸
- ¼ºÀÎ
- ÀÓºÎ
- ¼Ò¾Æ
- À¯¾Æ
Á¦8Àå »À¿Í °üÀý °Ç°º¸Á¶Á¦ ½ÃÀå Ã߻ꡤ¿¹Ãø : À¯Åë ä³Îº°
- ÁÖ¿ä µ¿Çâ : À¯Åë ä³Îº°
- ¾à±¹
- E-Commerce
- ½ÇÁ¡Æ÷
- ±âŸ À¯Åë ä³Î
Á¦9Àå »À¿Í °üÀý °Ç°º¸Á¶Á¦ ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°
- ÁÖ¿ä µ¿Çâ : Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ½ºÆäÀÎ
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- ÀϺ»
- Àεµ
- È£ÁÖ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- ºê¶óÁú
- ¸ß½ÃÄÚ
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦10Àå ±â¾÷ °³¿ä
- Bayer AG
- Amway
- BASF SE
- Vita Life Sciences Ltd.
- Glanbia plc
- Arazo Nutrition
- Reckitt Benckiser Group plc
- Nature's Bounty, Inc.
- NOW Foods
- GNC Holdings, LLC
KSA
¿µ¹® ¸ñÂ÷
Bone & Joint Health Supplements Industry is projected to grow at a CAGR of 7.5% from 2024 to 2032, driven by aging population. There is a rising prevalence of bone and joint-related issues, such as osteoporosis and arthritis. According to Lancet study, around one billion people globally are estimated to suffer from osteoarthritis by 2050, and as per the Lancet Rheumatology journal, around 15% of the global population aged 30 years or above had osteoarthritis in 2023.
People are increasingly adopting proactive measures to support their overall well-being, including the use of supplements that promote bone and joint health. With growing fitness trends and a focus on maintaining an active lifestyle, consumers are seeking products containing key ingredients such as calcium, vitamin D, and omega-3 fatty acids to enhance bone strength and flexibility.
The overall bone & joint health supplements industry is segmented on the basis of product, form, consumer, distribution channel, and region.
Omega-3 fatty acid segment is anticipated to witness substantial growth through 2032, as they exhibit anti-inflammatory properties that can alleviate joint pain. These essential fatty acids, found in fish oil, help in maintaining optimal bone density. The consumers are increasingly prioritizing natural approaches to healthcare, favoring the segment growth.
Powder segment is expected to observe a significant CAGR during 2023 and 2032, attributed to the bioavailability. Unlike traditional pills or capsules, powdered supplements can be quickly absorbed, allowing the body to utilize the essential nutrients. Additionally, the powder format provides greater flexibility in dosage customization, enabling consumers to easily adjust their intake based on individual needs.
Asia Pacific bone & joint health supplements market share will grow substantially between 2023 and 2032, favored by the emphasis on traditional practices such as ayurveda and traditional chinese medicine. The rising prevalence of sedentary lifestyle and urbanization in countries such as India and China has resulted in an increased rate of musculoskeletal issues, creating a demand for supplements that address these concerns. The adoption of innovative formulations, blending ancient methods with modern nutritional science, further stimulates the regional industry growth.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definition
- 1.2 Base estimates & calculations
- 1.3 Forecast calculation
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Primary
- 1.5.2 Secondary
- 1.5.2.1 Paid sources
- 1.5.2.2 Public sources
Chapter 2 Executive Summary
- 2.1 Bone & joint health supplements industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Form trends
- 2.1.5 Consumer trends
- 2.1.6 Distribution channel trends
Chapter 3 Bone & Joint Health Supplements Market Insights
- 3.1 Industry landscape, 2018 - 2032 (USD Million)
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing ageing population
- 3.2.1.2 Rising prevalence of bone-related disorders
- 3.2.1.3 Growing awareness and demand for dietary supplements
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Side effects and safety concerns associated with the supplements
- 3.2.2.2 Limited clinical data pertaining to the supplements
- 3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By form
- 3.3.3 By consumer
- 3.3.4 By distribution channel
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis, 2023
- 4.3 Competitive analysis of major market players, 2023
- 4.4 Competitive positioning matrix, 2023
- 4.5 Strategic dashboard, 2023
Chapter 5 Bone & Joint Health Supplements Market Estimates and Forecast, By Product, 2018-2032 (USD Million)
- 5.1 Key trends, by product
- 5.2 Vitamins & minerals
- 5.3 Collagen
- 5.4 Glucosamine-chondroitin
- 5.5 Omega-3 fatty acid
- 5.6 Other products
Chapter 6 Bone & Joint Health Supplements Market Estimates and Forecast, By Form, 2018-2032 (USD Million)
- 6.1 Key trends, by form
- 6.2 Capsules & tablets
- 6.3 Powders
- 6.4 Liquids
- 6.5 Other forms
Chapter 7 Bone & Joint Health Supplements Market Estimates and Forecast, By Consumer, 2018-2032 (USD Million)
- 7.1 Key trends, by consumer
- 7.2 Geriatric population
- 7.3 Adults
- 7.4 Pregnant women
- 7.5 Children
- 7.6 Infants
Chapter 8 Bone & Joint Health Supplements Market Estimates and Forecast, By Distribution Channel, 2018-2032 (USD Million)
- 8.1 Key trends, by distribution channel
- 8.2 Pharmacies
- 8.3 E-commerce
- 8.4 Brick & mortar
- 8.5 Other distribution channels
Chapter 9 Bone & Joint Health Supplements Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
- 9.1 Key trends, by region
- 9.2 North America
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
- 9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
- 10.1 Bayer AG
- 10.2 Amway
- 10.3 BASF SE
- 10.4 Vita Life Sciences Ltd.
- 10.5 Glanbia plc
- 10.6 Arazo Nutrition
- 10.7 Reckitt Benckiser Group plc
- 10.8 Nature's Bounty, Inc.
- 10.9 NOW Foods
- 10.10 GNC Holdings, LLC
°ü·ÃÀÚ·á